American Association for Cancer Research (AACR)

Coronavirus Information and Resources: Learn how the COVID-19 pandemic has created special challenges for cancer patients, survivors, and their families.

Learn More

Progress Against Cancer

The Week in Cancer News: A roundup of significant cancer research news from the past week, selected by the staff of Cancer Today magazine.

Learn More

Cancer Types

More than 17,500 people a year in the U.S. are diagnosed with esophageal cancer. Learn more about this type of cancer including the prevention, screening, and treatment options.

Learn More

Cancer Discoveries

Study: For Hispanics in the United States, age and ethnicity impact trust in health information.

Learn More

FDA Approvals

Read about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.

Learn More

Get Involved

Get involved with the AACR Foundation in support of lifesaving cancer research. Share your story, create a DIY fundraiser, participate in events and races (including virtual events), and much more.

Learn More

For Researchers

AACR Virtual Annual Meeting II

Revisit the AACR Virtual Annual Meeting II, which featured an opening plenary, clinical plenary sessions, the Presidential Address, award lectures, an educational program, minisymposia, and e-posters. Sessions available through September 30.

Learn More

Videos

Driving Progress Against Cancer

The American Association for Cancer Research (AACR) and our more than 47,000 members worldwide are advancing a scientifically bold agenda against the collection of devastating diseases we call cancer.

Keeping Breast Cancer at Bay with Immunotherapy

Eva was devastated to learn her triple-negative breast cancer had spread to her lungs and sternum, but immunotherapy has allowed her and her husband to enjoy retirement together.

Charles L. Sawyers, MD: Fellow of the AACR Academy

A physician-scientist and leader in the development of targeted therapies for cancer, Dr. Sawyers investigates the signaling pathways that drive the growth and drug resistance of cancer cells.